Aventis Pharma S.A. v. Amphastar Pharmaceuticals, Inc.
This text of 157 F. App'x 258 (Aventis Pharma S.A. v. Amphastar Pharmaceuticals, Inc.) is published on Counsel Stack Legal Research, covering Court of Appeals for the Federal Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.
Opinion
ORDER
Aventis Pharma S.A. et al. (Aventis) move to dismiss Amphastar Pharmaceuticals, Inc.’s appeal, 05-1539, of a claim construction ruling in Aventis Pharma S. A v. Amphastar Pharmaceuticals, Inc., 03-CV-887 (C.D.Cal. Oct. 21, 2004). Amphastar does not oppose.
Upon consideration thereof,
IT IS ORDERED THAT:
(1) Aventis’ unopposed motion to dismiss Amphastar’s appeal, 05-1539, is granted.
(2) All sides shall bear their own costs for 05-1539.
We note that Amphastar states that it "does not oppose Aventis’ Motion in so far as it seeks to dismiss Amphastar’s Cross-Appeal without prejudice.” However, it is not the practice of this court to dismiss with or without prejudice.
Free access — add to your briefcase to read the full text and ask questions with AI
Cite This Page — Counsel Stack
157 F. App'x 258, Counsel Stack Legal Research, https://law.counselstack.com/opinion/aventis-pharma-sa-v-amphastar-pharmaceuticals-inc-cafc-2005.